KR830003478A - 6-N-프로필-8α-메톡시메틸 또는 메틸메르캅토메틸 에르골린 유도체의 제조방법 - Google Patents
6-N-프로필-8α-메톡시메틸 또는 메틸메르캅토메틸 에르골린 유도체의 제조방법 Download PDFInfo
- Publication number
- KR830003478A KR830003478A KR1019800003793A KR800003793A KR830003478A KR 830003478 A KR830003478 A KR 830003478A KR 1019800003793 A KR1019800003793 A KR 1019800003793A KR 800003793 A KR800003793 A KR 800003793A KR 830003478 A KR830003478 A KR 830003478A
- Authority
- KR
- South Korea
- Prior art keywords
- propyl
- preparing
- methoxymethyl
- ergoline derivative
- methyl mercaptomethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 methyl mercaptomethyl ergoline derivative Chemical class 0.000 title 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80768 | 1979-10-01 | ||
| US06/080,768 US4246265A (en) | 1979-10-01 | 1979-10-01 | 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR830003478A true KR830003478A (ko) | 1983-06-20 |
Family
ID=22159504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019800003793A Ceased KR830003478A (ko) | 1979-10-01 | 1980-09-30 | 6-N-프로필-8α-메톡시메틸 또는 메틸메르캅토메틸 에르골린 유도체의 제조방법 |
Country Status (32)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH644606A5 (de) * | 1980-09-23 | 1984-08-15 | Sandoz Ag | Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten. |
| DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
| US4675322A (en) * | 1984-12-10 | 1987-06-23 | Eli Lilly And Company | 1-Substituted-6-n-propyl-8β-methylthio-methylergolines |
| US4683313A (en) * | 1985-06-24 | 1987-07-28 | Eli Lilly And Company | 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles |
| US4782152A (en) * | 1985-08-16 | 1988-11-01 | Eli Lilly And Company | Decyanation of pergolide intermediate |
| US4772709A (en) * | 1985-10-01 | 1988-09-20 | Eli Lilly And Company | Process of making ketoalkanol esters of dihydrolysergic acid |
| FR2589734B1 (fr) * | 1985-11-13 | 1988-09-02 | Roussel Uclaf | Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique |
| US5668155A (en) * | 1988-05-10 | 1997-09-16 | The General Hospital Corporation | Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
| IT1307934B1 (it) | 1999-01-27 | 2001-11-29 | Poli Ind Chimica Spa | Processo per la preparazione di derivati alchimercaptometilergolinici. |
| US6388079B1 (en) * | 2000-08-29 | 2002-05-14 | Scinopharm Singapore Pte Ltd. | Process for preparing pergolide |
| US7019140B2 (en) | 2002-03-15 | 2006-03-28 | Antibioticos S.P.A. | Process for the synthesis of pergolide |
| US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| GB0409785D0 (en) * | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
| US7339060B2 (en) | 2005-03-23 | 2008-03-04 | Resolution Chemicals, Ltd. | Preparation of cabergoline |
| GB0505965D0 (en) * | 2005-03-23 | 2005-04-27 | Resolution Chemicals Ltd | Preparation of cabergoline |
| US20070197576A1 (en) * | 2006-02-08 | 2007-08-23 | Resolution Chemicals Limited | Production of Cabergoline and Novel Polymorphic Form Thereof |
| MX388192B (es) | 2014-09-25 | 2025-03-19 | Boehringer Ingelheim Vetmedica Gmbh | Tratamiento de combinación y/o prevención de trastornos metabólicos en animales equinos. |
| WO2019234069A1 (en) | 2018-06-08 | 2019-12-12 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising pergolide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
| DE2657771A1 (de) * | 1976-01-02 | 1977-07-14 | Sandoz Ag | Neue organische verbindungen, ihre verwendung und herstellung |
| US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| US4202979A (en) * | 1979-01-11 | 1980-05-13 | Eli Lilly And Company | 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
-
1979
- 1979-10-01 US US06/080,768 patent/US4246265A/en not_active Expired - Lifetime
-
1980
- 1980-09-25 ZA ZA00805959A patent/ZA805959B/xx unknown
- 1980-09-25 BE BE1/9966A patent/BE885385A/fr not_active IP Right Cessation
- 1980-09-25 NZ NZ195053A patent/NZ195053A/xx unknown
- 1980-09-25 RO RO102217A patent/RO81115B/ro unknown
- 1980-09-25 FR FR8020639A patent/FR2466465A1/fr active Granted
- 1980-09-25 GR GR62959A patent/GR70067B/el unknown
- 1980-09-25 CA CA000361035A patent/CA1137079A/en not_active Expired
- 1980-09-25 FI FI803025A patent/FI803025A7/fi not_active Application Discontinuation
- 1980-09-25 PL PL22691780A patent/PL226917A1/xx unknown
- 1980-09-26 IL IL61143A patent/IL61143A0/xx unknown
- 1980-09-26 CS CS806515A patent/CS223834B2/cs unknown
- 1980-09-26 PT PT71840A patent/PT71840B/pt unknown
- 1980-09-27 EG EG80594A patent/EG14583A/xx active
- 1980-09-29 YU YU02472/80A patent/YU247280A/xx unknown
- 1980-09-29 BG BG049173A patent/BG34908A3/xx unknown
- 1980-09-29 IT IT25004/80A patent/IT1133631B/it active
- 1980-09-29 HU HU802373A patent/HU181766B/hu unknown
- 1980-09-29 JP JP13668780A patent/JPS5657787A/ja active Pending
- 1980-09-30 CH CH730780A patent/CH645642A5/fr not_active IP Right Cessation
- 1980-09-30 AU AU62807/80A patent/AU529508B2/en not_active Ceased
- 1980-09-30 GB GB8031440A patent/GB2058790B/en not_active Expired
- 1980-09-30 PH PH24648A patent/PH15021A/en unknown
- 1980-09-30 ES ES495520A patent/ES8200697A1/es not_active Expired
- 1980-09-30 IE IE2036/80A patent/IE50429B1/en unknown
- 1980-09-30 EP EP80303447A patent/EP0026671B1/en not_active Expired
- 1980-09-30 DE DE8080303447T patent/DE3069771D1/de not_active Expired
- 1980-09-30 KR KR1019800003793A patent/KR830003478A/ko not_active Ceased
- 1980-09-30 DK DK413780A patent/DK413780A/da not_active Application Discontinuation
- 1980-09-30 AT AT0487480A patent/AT373251B/de not_active IP Right Cessation
- 1980-09-30 DD DD80224224A patent/DD153372A5/de unknown
- 1980-10-01 SU SU802984351A patent/SU976851A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR830003478A (ko) | 6-N-프로필-8α-메톡시메틸 또는 메틸메르캅토메틸 에르골린 유도체의 제조방법 | |
| KR840008014A (ko) | 오메프라졸염의 제조방법 | |
| KR840005083A (ko) | 항고혈압제로서 유용한 아미노산유도체의 제조방법 | |
| KR830007508A (ko) | (-)n-메틸-3-(2-메틸페녹스)-3-페닐프로필아민의 제조방법 | |
| KR840004106A (ko) | 4급 6,11-디하이드로-디벤조-[b,e]-티에핀-11-N-알킬-노르스코핀 에테르의 제조방법 | |
| KR920702348A (ko) | 퀴놀론 카르복실산 유도체 | |
| KR890005088A (ko) | 4- 아미노피리딘 유도체 및 그의 산 부가염 | |
| KR890014435A (ko) | 페녹시알킬카복실산 유도체 및 이의 제조방법 | |
| KR880011103A (ko) | 5-아미노-4,6-디할로게노피리딘의 제조방법 | |
| KR830004320A (ko) | 퀴나졸린 유도체의 제조방법 | |
| KR830008990A (ko) | 2-아미노-3-(할로벤조일)-메틸페닐아세트산 유도체의 제조방법 | |
| ES8106536A1 (es) | Procedimiento de preparacion de nuevos derivados ergol-8- enos y ergolinos y de sus sales de adicion acidas | |
| KR840004420A (ko) | N-(1,3-디티올린-2-알리덴)아닐린 유도체의 제조방법 | |
| KR840004747A (ko) | 강심제 퀸아졸린의 제조방법 | |
| KR850005441A (ko) | 3-알콕시-2-(n-피롤리디노)-n-피리딜-n-푸릴메틸(또는 푸릴티에닐)-프로필아민의 제조방법 | |
| KR830002778A (ko) | 결정화 방법 | |
| KR890008151A (ko) | 키놀린 카르복산의 유도체 | |
| KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 | |
| KR830006285A (ko) | 벤조퀴놀리진의 제조방법 | |
| KR860006461A (ko) | 항알레르기 작용을 갖는 화합물의 제조방법 | |
| KR860002451A (ko) | 아미드 화합물의 제조방법 | |
| KR920009788A (ko) | 수용성 이산화티오요소 유도체 및 그의 제조방법 | |
| KR840000482A (ko) | 시스틴 유도체의 제조방법 | |
| KR920014774A (ko) | 페녹시알킬카복실산 유도체 및 이의 제조방법 | |
| KR880009026A (ko) | 리파마이신 유도체 염 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19800930 |
|
| PG1501 | Laying open of application | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19840224 Patent event code: PE09021S01D |
|
| PE0601 | Decision on rejection of patent |
Patent event date: 19841008 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19840224 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |